The goal of this clinical trial is to learn about the effects of Docosahexaenoic acid (DHA) in reducing the incidence of premature birth in threatened preterm labor The main questions it aims to answer are: * Can DHA supplementation reduce the incidence of premature birth in threatened preterm labor? * How does DHA supplementation affect pregnancy outcomes? Participants were organized into two groups * Group 1 (Intervention) Participants will be asked to take a DHA 1000mg per day * Group 2 (control) Participant will not need to take a DHA
Threatened preterm labor is defined as regular uterine contractions occurring before 37 completed weeks of gestation, without any cervical dilation.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
60
Pregnant women will be ask to take a DHA 1000 mg per days at bedtime until delivery or 37 week of gestational age
KhonKaenU
Khon Kaen, KhonKaen, Thailand
Number of Participants with preterm birth
Delivery at less than 37 weeks of gestational age
Time frame: at delivery time
Rate of low birth weight neonate
Newborn's weight at birth is less than 2500g
Time frame: at delivery time
Rate of Neonatal Intensive care unit admission
newborn need neonatal intensive care
Time frame: at delivery time
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.